BioStock: New CEO brings deal-making experience to Immunicum

Last month, Swedish biotech Immunicum announced the recruitment of a new CEO, Sven Rohmann. The change in leadership comes at an opportune time for the company, when partnering is on the horizon, and Rohmann’s extensive business development experience will be of great value to the company. BioStock was able to get in touch with the new CEO to get a sense of his vision for Immunicum.

Read the full interview with Sven Rohmann at biostock.se:

https://www.biostock.se/en/new-ceo-brings-deal-making-experience-to-immunicum/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se